Medical Devices Investors & VC Firms
1641 firms in this list, with a median first check of $500K. 343 of them lead rounds. Generated from verified public data and updated continuously.
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people
Brightstone Venture Capital
MinneapolisSeed–Growth$250K – $10M
11 people
Fountain Healthcare Partners
DublinSeed–Series A$10.8M – $16.2M
8 people
Pix Vine Capital
SingaporeSeed–Series A$250K – $500K
1 person
Noetic
TorontoSeed–Series A
13 people
Leawood Venture Capital Llc
LeawoodSeed–Series A$1M – $3M
12 people
Phaze Ventures
MuscatPre-Seed–Series A
9 people
Suncoast Ventures
Walnut CreekPre-Seed–Series A
15 people
Sv Tech Ventures, Inc.
Palo AltoSeed–Series A
9 people
Formation Venture Engineering
BostonPre-Seed
20 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
Ally Bridge Group
New YorkGrowth–Late Stage
7 people
Angel Academe
LondonSeed–Series A$11K – $385K
4 people
Monte Carlo Capital
Pre-Seed–Series A$350K – $1.5M
4 people
Rock Springs Capital
BaltimoreLate Stage
13 people
TAU Ventures
Tel AvivPre-Seed–Seed$1M
7 people
BioHealth Innovation, Inc.
Rockville
21 people
Micron Ventures
BoisePre-Seed–Series A
12 people
Applied Ventures
Santa ClaraSeed–Series A$500K – $3M
16 people
ATON GmbH
München
19 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Growth$16.2M
16 people
Darwin Venture Management
TaipeiSeed–Late Stage$1M – $5M
19 people
Mount Judi Ventures
BengaluruPre-Seed–Series B
16 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Related lists
Investors & VC Firms in North America (12829)Investors & VC Firms in United States (11877)Investors & VC Firms in Europe (5831)Investors & VC Firms in Global (4737)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4547)SaaS Investors & VC Firms (4223)Healthtech Investors & VC Firms (4191)Enterprise Software Investors & VC Firms (4100)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.






























































































